Transfection of multiple pulmonary cell types following intravenous injection of PEI-DNA in normal and CFTR mutant mice

Journal of Gene Medicine

Volumn 8, Issue 1, 2006, Pages 82-89

  Dif, Fariel ^a   Djediat, Chakib ^a   Alegria, Olinda ^a   Demeneix, Barbara ^a   Levi, Giovanni ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Cystic fibrosis; Electron microscopy; Gene delivery; Lung; Mouse model; Polyethylenimine

Indexed keywords

DNA; POLYETHYLENEIMINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA VECTOR; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC MODEL; GENETIC TRANSFECTION; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REPORTER GENE; TRANSGENE;

ANIMALS; BETA-GALACTOSIDASE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOTHELIAL CELLS; FEMALE; GENETIC VECTORS; INJECTIONS, INTRAVENOUS; LUCIFERASES; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED CFTR; POLYETHYLENEIMINE; TRANSFECTION;

ANIMALIA;

EID: 31644450510     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.831     Document Type: Article

References (45)

1. Ferrari S, Pettenazzo A, Garbati N, et al. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim Biophys Acta 1999; 1447: 219-225.
2. Rudolph C, Lausier J, Naundorf S, et al. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000; 2: 269-278.
3. Allo JC, Midoux P, Merten M, et al. Efficient gene transfer into human normal and cystic fibrosis tracheal gland serous cells with synthetic vectors. Am J Respir Cell Mol Biol 2000; 22: 166-175.
4. Gautam A, Densmore CL, Xu B, et al. Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther 2000; 2: 63-70.
5. Gautam A, Densmore CL, Golunski E, et al. Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther 2001; 3: 551-556.
6. Densmore CL. Polyethyleneimine-based gene therapy by inhalation. Expert Opin Biol Ther 2003; 3: 1083-1092.
7. Wiseman JW, Goddard CA, McLelland D, et al. A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Ther 2003; 10: 1654-1662.
8. Thomas M, Lu JJ, Ge Q, et al. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci U S A 2005; 102: 5679-5684.
9. Köping-Höggård M, Issa MM, Kohler T, et al. A miniaturized nebulization catheter for improved gene delivery to the mouse lung. J Gene Med 2005; 7: in press.
10. Rudolph C, Ortiz A, Schillinger U, et al. Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J Gene Med 2005; 7: 59-66.
11. Goula D, Benoist C, Mantero S, et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 1998; 5: 1291-1295.
12. Goula D, Becker N, Lemkine GF, et al. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 2000; 7: 499-504.
13. Zou SM, Erbacher P, Remy JS, et al. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2000; 2: 128-134.
14. Zinselmeyer BH, Beggbie N, Uchegbu IF, et al. Quantification of beta-galactosidase activity after non-viral transfection in vivo. J Control Release 2003; 91: 201-208.
15. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992; 256: 774-779.
16. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
17. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
18. Anderson MP, Berger HA, Rich DP, et al. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 1991; 67: 775-784.
19. Li M, McCann JD, Anderson MP, et al. Regulation of chloride channels by protein kinase C in normal and cystic fibrosis airway epithelia. Science 1989; 244: 1353-1356.
20. Anderson MP, Gregory RJ, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991; 253: 202-205.
21. Koller BH, Kim HS, Latour AM, et al. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc Natl Acad Sci U S A 1991; 88: 10 730-10 734.
22. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
23. Zeiher BG, Eichwald E, Zabner J, et al. A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 1995; 96: 2051-2064.
24. Kent G, Iles R, Bear CE, et al. Lung disease in mice with cystic fibrosis. J Clin Invest 1997; 100: 3060-3069.
25. Dorin JR, Farley R, Webb S, et al. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther 1996; 3: 797-801.
26. Welsh MJ, Smith AE. Cystic fibrosis. Sci Am 1995; 273: 52-59.
27. Konstan MW, Davis PB, Wagener JS, et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 2004; 15: 1255-1269.
28. Zeitlin PL, Boyle MP, Guggino WB, et al. A phase I trial of intranasal Moli1901 for cystic fibrosis. Chest 2004; 125: 143-149.
29. Albelda SM, Wiewrodt R, Zuckerman JB, Gene theraphy for lung disease: hype or hope? Ann Intern Med 2000; 132: 649-660.
30. Bellon G, Michel-Calemard L, Thouvenot D, et al. Cystic fibrosis (CF) gene therapy. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Pediatr Pulmonol Suppl 1997; 16: 278-279.
31. Zuckerman JB, Robinson CB, McCoy KS, et al. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther 1999; 10: 2973-2985
32. Flotte T, Carter B, Conrad C, et al. A phase I study of an andeno-associated virus-CFTR gene vector in adult CF patients with mild a lung disease. Hum Gene Ther 1996; 7: 1145-1159
33. Halbert CL, Miller AD. AAV-mediated gene transfer to mouse lungs. Methods Mol Biol 2004; 246: 201-212.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
35. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712-717.
36. Schwartz B, Benoist C, Abdallah B, et al. Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/ DNA charge ratio. Hum Gene Ther 1995; 6: 1515-1524.
37. Weis J, Fine SM, David C, et al. Integration site-dependent expression of a transgene reveals specialized features of cells associated with neuromuscular junctions. J Cell Biol 1991; 113: 1385-1397.
38. Johnson LG, Olsen JC, Sarkadi B, et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992; 2: 21-25.
39. Goldman MJ, Yang Y, Wilson JM. Gene theraphy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nat Genet 1995; 9: 126-131.
40. Ramalho AS, Beck S, Meyer M, et al. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 2002; 27: 619-627.
41. Griesenbach U, Geddes DM, Alton EW. Gene theraphy for cystic fibrosis: an example for lung gene theraphy. Gene Ther 2004; 11(Suppl 1): S43-50.
42. Bragonzi A, Dina G, Villa A, et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000; 7: 1753-1760.
43. Li S, Tan Y, Viroonchatapan E, et al. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000; 278: L504-511.
44. Mall M, Grubb BR, Harkema JR, et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004; 10: 487-493.
45. Chollet P, Favrot MC, Hurbin A, et al. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med 2002; 4: 84-91.